Production of Adult Human Synovial Fluid-Derived Mesenchymal Stem Cells in Stirred-Suspension Culture

The chondrogenic potential of synovial fluid-derived mesenchymal stem cells (SF-MSCs) supports their use in cartilage regeneration strategies. However, their paucity in synovial fluid necessitates their proliferation in culture to generate clinically relevant quantities. Here it was determined that...

Full description

Saved in:
Bibliographic Details
Main Authors: Kristen D. Jorgenson, David A. Hart, Roman Krawetz, Arindom Sen
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2018/8431053
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556220175613952
author Kristen D. Jorgenson
David A. Hart
Roman Krawetz
Arindom Sen
author_facet Kristen D. Jorgenson
David A. Hart
Roman Krawetz
Arindom Sen
author_sort Kristen D. Jorgenson
collection DOAJ
description The chondrogenic potential of synovial fluid-derived mesenchymal stem cells (SF-MSCs) supports their use in cartilage regeneration strategies. However, their paucity in synovial fluid necessitates their proliferation in culture to generate clinically relevant quantities. Here it was determined that 125 mL stirred suspension bioreactors utilizing Cytodex-3 microcarrier beads represent a viable platform for the proliferation of these cells. During the inoculation phase, a bead loading of 2 g/L, an inoculation ratio of 4.5 cells/bead, and continuous agitation at 40 rpm in a medium with 5% serum resulted in high cell attachment efficiencies and a subsequent overall cell fold expansion of 5.7 over 8 days. During the subsequent growth phase, periodic addition of new microcarriers and fresh medium increased culture longevity, resulting in a 21.3 cell fold increase over 18 days in the same vessel without compromising the defining characteristics of the cells. Compared to static tissue culture flasks, a bioreactor-based bioprocess requires fewer handling steps, is more readily scalable, and for the same cell production level, has a lower operating cost as it uses approximately half the medium. Therefore, stirred suspension bioreactors incorporating microcarrier technology represent a viable and more efficient platform than tissue culture flasks for the generation of SF-MSCs in culture.
format Article
id doaj-art-cc67cd68c23344dd92b55f4a057f2f05
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-cc67cd68c23344dd92b55f4a057f2f052025-02-03T05:46:01ZengWileyStem Cells International1687-966X1687-96782018-01-01201810.1155/2018/84310538431053Production of Adult Human Synovial Fluid-Derived Mesenchymal Stem Cells in Stirred-Suspension CultureKristen D. Jorgenson0David A. Hart1Roman Krawetz2Arindom Sen3Pharmaceutical Production Research Facility (PPRF), Schulich School of Engineering, University of Calgary, 2500 University Drive NW, Calgary, AB, T2N 1N4, CanadaMcCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, AB, T2N 4Z6, CanadaMcCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, AB, T2N 4Z6, CanadaPharmaceutical Production Research Facility (PPRF), Schulich School of Engineering, University of Calgary, 2500 University Drive NW, Calgary, AB, T2N 1N4, CanadaThe chondrogenic potential of synovial fluid-derived mesenchymal stem cells (SF-MSCs) supports their use in cartilage regeneration strategies. However, their paucity in synovial fluid necessitates their proliferation in culture to generate clinically relevant quantities. Here it was determined that 125 mL stirred suspension bioreactors utilizing Cytodex-3 microcarrier beads represent a viable platform for the proliferation of these cells. During the inoculation phase, a bead loading of 2 g/L, an inoculation ratio of 4.5 cells/bead, and continuous agitation at 40 rpm in a medium with 5% serum resulted in high cell attachment efficiencies and a subsequent overall cell fold expansion of 5.7 over 8 days. During the subsequent growth phase, periodic addition of new microcarriers and fresh medium increased culture longevity, resulting in a 21.3 cell fold increase over 18 days in the same vessel without compromising the defining characteristics of the cells. Compared to static tissue culture flasks, a bioreactor-based bioprocess requires fewer handling steps, is more readily scalable, and for the same cell production level, has a lower operating cost as it uses approximately half the medium. Therefore, stirred suspension bioreactors incorporating microcarrier technology represent a viable and more efficient platform than tissue culture flasks for the generation of SF-MSCs in culture.http://dx.doi.org/10.1155/2018/8431053
spellingShingle Kristen D. Jorgenson
David A. Hart
Roman Krawetz
Arindom Sen
Production of Adult Human Synovial Fluid-Derived Mesenchymal Stem Cells in Stirred-Suspension Culture
Stem Cells International
title Production of Adult Human Synovial Fluid-Derived Mesenchymal Stem Cells in Stirred-Suspension Culture
title_full Production of Adult Human Synovial Fluid-Derived Mesenchymal Stem Cells in Stirred-Suspension Culture
title_fullStr Production of Adult Human Synovial Fluid-Derived Mesenchymal Stem Cells in Stirred-Suspension Culture
title_full_unstemmed Production of Adult Human Synovial Fluid-Derived Mesenchymal Stem Cells in Stirred-Suspension Culture
title_short Production of Adult Human Synovial Fluid-Derived Mesenchymal Stem Cells in Stirred-Suspension Culture
title_sort production of adult human synovial fluid derived mesenchymal stem cells in stirred suspension culture
url http://dx.doi.org/10.1155/2018/8431053
work_keys_str_mv AT kristendjorgenson productionofadulthumansynovialfluidderivedmesenchymalstemcellsinstirredsuspensionculture
AT davidahart productionofadulthumansynovialfluidderivedmesenchymalstemcellsinstirredsuspensionculture
AT romankrawetz productionofadulthumansynovialfluidderivedmesenchymalstemcellsinstirredsuspensionculture
AT arindomsen productionofadulthumansynovialfluidderivedmesenchymalstemcellsinstirredsuspensionculture